An immune response that likely evolved to help fight infections appears to be the mechanism that drives human immunodeficiency virus (HIV) into a latent state, lurking in cells only to erupt anew, researchers at Duke Health report.
Wearable maker ActiGraph acquires assets from Biofourmis to boost clinical trial offerings
ActiGraph, a maker of wearables and software used by drug companies in clinical trials, on Tuesday announced it acquired the life sciences business of Biofourmis,